Digoxin Immune Fab indications and usage: Difference between revisions

Jump to navigation Jump to search
Abdurahman Khalil (talk | contribs)
Created page with "__NOTOC__ {{Digoxin immune fab}} {{CMG}}; {{AE}} {{AK}} '''''For patient information about Digoxin immune fab, click here.''''' ..."
 
GeraldChi (talk | contribs)
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Digoxin immune fab#Adult Indications and Dosage]]
{{Digoxin immune fab}}
{{CMG}}; {{AE}} {{AK}}
 
'''''For patient information about Digoxin immune fab, click [[Digoxin immune fab (patient information)|here]].'''''
 
==INDICATIONS AND USAGE==
 
DigiFab is indicated for the treatment of patients with life-threatening or potentially life-threatening [[digoxin toxicity ]]or overdose. Although designed specifically to treat [[digoxin overdose]], a product very similar to DigiFab (Digibind) has been used successfully to treat life-threatening digitoxin overdose.7 Since human experience is limited, and the consequences of repeated exposure are unknown, DigiFab is not indicated for milder cases of digitalis toxicity.
 
====Clinical conditions requiring administration of DigiFab include:===
 
Known suicidal or accidental consumption of fatal doses of digoxin, including ingestion of 10 mg or more of digoxin in previously healthy adults, or 4 mg for more than 0.1 mg/kg) in previously healthy children, or ingestion causing steady state serum concentrations greater than 10 ng/mL;
Chronic ingestions causing steady-state serum digoxin concentrations exceeding 6 ng/mL in adults or 4 ng/mL in children; and,
Manifestations of life-threatening toxicity due to digoxin overdose, including severe [[ventricular arrhythmias]] (such as [[ventricular tachycardia]] or [[fibrillation]]), progressive [[bradycardia]], and [[second degree heart block|second]] or [[third degree heart block]] not responsive to atropine, serum potassium levels exceeding 5.5 mEq/L in adults or 6 mEq/L in children with rapidly progressive signs and symptoms of digoxin toxicity.
 
 
 
 
 
==References==
 
{{Reflist|2}}
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6832767f-db6b-4eea-b88b-bdfc905749e1
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 02:11, 22 July 2014